S0
S00.F Spire Healthcare Group plc
- Market cap
- EUR 1.24B
- P/E
- -
- P/B
- 1.30x
- ROE
- 2.2%
- Dividend yield
- 0.61%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is S00.F undervalued?
Graham numberThe Graham number of Spire Healthcare Group plc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Spire Healthcare Group plc fundamental analysis
No fundamental analysis for Spire Healthcare Group plc yet.
Spire Healthcare Group plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Spire Healthcare Group plc
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and ph…
Full company profileSpire Healthcare Group plc financial statements
Spire Healthcare Group plc annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 926M | 932M | 931M | 981M | 920M | 1.11B | 1.20B | 1.36B | 1.51B | 1.58B |
| Gross Profit | 441M | 440M | 434M | 451M | 456M | 491M | 538M | 624M | 684M | 716M |
| Operating Income | 108M | 92.1M | 54.2M | 97.6M | 66.7M | 80.0M | 92.4M | 127M | 125M | 119M |
| EBITDA | - | 91.2M | 97.2M | 185M | -51.9M | 183M | 188M | 230M | 249M | 242M |
| Net Income | 53.6M | 16.8M | 11.3M | 7.20M | -234M | -9.70M | 8.60M | 27.3M | 25.4M | 16.4M |
| EPS | - | 0.04 | 0.03 | 0.02 | -0.58 | -0.02 | 0.02 | 0.07 | 0.06 | 0.04 |
| Balance Sheet | ||||||||||
| Total Assets | 1.72B | 1.73B | 1.71B | 2.29B | 2.10B | 2.24B | 2.16B | 2.29B | 2.34B | 2.38B |
| Total Liabilities | 689M | 696M | 685M | 1.35B | 1.40B | 1.53B | 1.43B | 1.55B | 1.60B | 1.63B |
| Shareholders' Equity | 1.04B | 1.04B | 1.03B | 940M | 707M | 710M | 731M | 740M | 748M | 743M |
| Cash & Short-term Investments | 67.9M | 39.2M | 47.7M | 90.8M | 106M | 203M | 74.2M | 49.6M | 41.2M | 34.7M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 177M | 124M | 183M | 202M | 160M | 184M | 182M | 216M | 236M | 242M |
| Capital Expenditure | 150M | 119M | 73.7M | 60.6M | 46.6M | 69.3M | 87.7M | 84.4M | 112M | 78.5M |
| Free Cash Flow | - | 4.80M | 44.0M | 141M | 113M | 115M | 93.9M | 131M | 124M | 164M |
| Ratios | ||||||||||
| ROE | 5.2% | 1.6% | 1.1% | 0.8% | -33.1% | -1.4% | 1.2% | 3.7% | 3.4% | 2.2% |
| ROA | 3.1% | 1.0% | 0.7% | 0.3% | -11.1% | -0.4% | 0.4% | 1.2% | 1.1% | 0.7% |
| Net Profit Margin | 5.8% | 1.8% | 1.2% | 0.7% | -25.4% | -0.9% | 0.7% | 2.0% | 1.7% | 1.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Spire Healthcare Group plc dividends
- Dividend yield
- 0.61%
- Forward dividend
- 0.02 EUR
- Payout ratio
- 56.1%
- Ex-dividend date
- May 21, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | GBP 9.20M | 0.02 | 56.1% |
| 2024 | GBP 8.50M | 0.02 | 33.5% |
| 2023 | GBP 2.00M | 0.00 | 7.3% |
| 2022 | GBP 100K | 0.00 | 1.2% |
| 2021 | GBP 100K | 0.00 | - |
| 2020 | GBP 100K | 0.00 | - |
| 2019 | EUR 15.2M | 0.04 | 211.1% |
| 2018 | EUR 15.2M | 0.04 | 134.5% |
| 2017 | EUR 15.2M | 0.04 | 90.5% |
| 2016 | EUR 14.8M | - | 27.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Spire Healthcare Group plc
- Insiders 31.54%
- Institutions 55.78%
- Public & others 12.68%
- Shares outstanding 401M
- Free float 205M
Spire Healthcare Group plc company profile
- Company name
- Spire Healthcare Group plc
- Ticker
- S00.F
- ISIN
- GB00BNLPYF73
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 17,800
- Fiscal year end
- December
- Address
- 3 Dorset Rise, London, United Kingdom, EC4Y 8EN
- Phone
- 44 20 7427 9000
- Website
- spirehealthcare.com
About Spire Healthcare Group plc
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
Spire Healthcare Group plc management
10- Sir David Morgan SlomanInterim CEO & Vice Chairman of the Board · born 1961
- Mr. Harbant Singh SamraCFO & Executive Director · born 1979
- Sir Ian Michael Cheshire M.A.Advisor · born 1959
- Prof. Lisa Jane GrantGroup Chief Nursing Officer & COO · born 1976
- Ms. Amie GramlickDirector of Commercial Finance & Investor Relations
- Mr. Mantraraj Dipak BudhdevGroup General Counsel, Company Secretary & Chief People Officer · born 1986
- Mr. Peter CorfieldChief Commercial Officer
- Mr. Derrick Michael FarrellChief Executive Officer of Vita Health Group
- Dr. Catherine Mary CaleGroup Medical Director
- Ms. Rebecca HarperGroup Corporate Affairs Director